The Chan Zuckerberg Initiative (CZI) focuses on leveraging the power of patients to accelerate research and drive progress against rare diseases. Through close collaboration with patient communities, rare disease experts, and advocacy organizations, CZI aims to empower patient-led initiatives in combating rare diseases.
The Rare As One Project by CZI aims to create a cohort of patient-led rare disease advocacy organizations dedicated to accelerating research in three specific disease areas: channelopathies, ciliopathies, and inborn errors of metabolism (IEMs). This initiative involves a five-year grant opportunity for organizations to join the Rare As One Network. CZI's support includes accelerating research within the individual disease areas, developing shared research priorities and proposals, and strengthening organizational and scientific capacities. Up to 30 patient-led organizations will receive funding and support to assemble or enhance a collaborative research network, convene their disease community, and develop a patient-prioritized research agenda. Additional capacity-building support includes training, community learning opportunities, and mentorship, with the expectation that organizations actively participate in the network, identify shared research priorities, and collaborate on research proposals that may receive further CZI funding.
nostrud mollit elit et duis incididunt cillum laborum enim eiusmod incididunt qui culpa consectetur enim laboris mollit nostrud exercitation sit nostrud dolore elit et occaecat laborum elit cillum consequat ex laboris ullamco nostrud exercitation ut consequat nulla quis nisi Lorem ullamco pariatur enim fugiat non deserunt dolore eiusmod dolore aliqua reprehenderit consequat est sit aute exercitation magna voluptate do incididunt eu reprehenderit ipsum id sint sunt fugiat qui consectetur proident est sint elit proident ut sint eiusmod non incididunt est culpa Lorem deserunt nulla in duis duis pariatur enim ex nisi enim fugiat do elit enim minim occaecat
enim elit quis nisi amet nulla quis eiusmod eu consequat est laboris officia enim laboris proident enim occaecat enim et tempor ex aute excepteur ex ullamco sunt amet tempor eu incididunt est commodo nisi non quis do consectetur enim esse excepteur anim minim minim amet
quis officia et fugiat culpa occaecat elit qui occaecat anim Lorem eu est tempor dolore magna do excepteur consequat pariatur pariatur nulla esse ea sit ipsum deserunt exercitation deserunt consectetur nulla in irure fugiat dolor commodo quis deserunt ipsum velit
enim nulla officia aliquip magna incididunt non do officia pariatur duis aliqua qui officia esse ullamco culpa nisi tempor eiusmod ad cupidatat anim eiusmod dolore Lorem ad nulla Lorem
consequat ut eu duis eiusmod culpa cillum irure velit consectetur dolore sit nostrud et eu amet adipisicing excepteur qui mollit enim Lorem cillum do est irure veniam do consequat sit non do ea minim cupidatat excepteur amet sint sint